About Us

• We are a not-for-profit contract research organization.
• Our scientists have extensive experience in drug discovery research.
• We have experience in developing, validating and implementing high throughput screening assays for a broad range of drug targets in central nervous system disease, inflammation, infectious diseases, and oncology.
• We have an extremely diverse library containing 100,000 drugable compounds.
• We require no licensing fees or royalties.

Senior Scientific Staff

• Robert Kilkuskie, Ph.D., is the Senior Director of the Michigan High Throughput Screening Center.  He has over fifteen years of drug discovery experience in both pharmaceutical and biotech companies.  Dr. Kilkuskie has over twenty scientific publications and three issued patents. Dr. Kilkuskie currently serves as a reviewer for the National Institute of Health (NIH) Molecular Libraries Screening Center Network.
• Darryl Chapman, BA is the Associate Director of the Michigan High Throughput Screening Center.  He has over twenty five years of research experience, including ten years in high throughput screening. Mr. Chapman has nine scientific publications.
• Steven Vroegop, MS is the Associate Director of the Michigan High Throughput Screening Center.  He has over twenty years of drug discovery experience including, ten years in high throughput screening. Mr. Vroegop has fifteen scientific publications.
• Debra Bevis MS is a Research Scientist at the Michigan High Throughput Screening Center. She has over twenty years of drug discovery experience, including being a key member of the planning team for Pharmacia's HTS center.

Scientific Advisory Board

• Douglas Morton, Ph.D. (Chair), Founder, PharmMor Consulting
• Stephen Buxer, Ph.D., Principal, PharmOptima, Inc.
• Rick Hay, M.D., Ph.D., Deputy Director, Van Andel Research Institute
• John McCall, Ph.D., Founder, PharMac Consulting
• Charles Spilman, Ph.D., Retired Head of Screening, Pharmacia

Click here for a complete brochure.